Active Health Foods, Inc. (AHFD)

Achilles Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2013	FY 2012	FY 2011
Period Ending	Sep 30, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Net Income	-0.01	-0.01	-	-1.36	-5.23	-0.1
Other Amortization	-	-	-	0.4	0.03	-
Stock-Based Compensation	-	-	-	0.43	4.88	0.05
Other Operating Activities	-	-	-	0.39	0.12	0
Change in Accounts Receivable	-	-	-	0.03	-0.03	-
Change in Inventory	-	-	-	-0.02	-0.09	-0.03
Change in Accounts Payable	0.01	0.01	-	0.01	0.04	-0
Change in Other Net Operating Assets	-	-	-	-	0.01	-0.01
Operating Cash Flow	-	-	-	-0.13	-0.27	-0.09
Short-Term Debt Issued	-	-	-	0.3	0.29	0.09
Total Debt Issued	-	-	-	0.3	0.29	0.09
Short-Term Debt Repaid	-	-	-	-0.18	-0.07	-0.03
Total Debt Repaid	-	-	-	-0.18	-0.07	-0.03
Net Debt Issued (Repaid)	-	-	-	0.12	0.22	0.07
Issuance of Common Stock	-	-	-	0.01	0.05	0.03
Financing Cash Flow	-	-	-	0.13	0.27	0.09
Net Cash Flow	-	-	-	-0	0	0
Levered Free Cash Flow	-	-	-	0.37	1.73	-0.21
Unlevered Free Cash Flow	-	-	-	0.24	1.7	-0.21
Change in Net Working Capital	-	-	-	-0.06	-0.06	0.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.